Physician profile
Jean Lang
NPI 1295835395
$2,138.21
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $398 · 2020: $380 · 2021: $520 · 2022: $299 · 2023: $434 · 2024: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $540.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $777.68 | 2019-2024 | Mounjaro |
| Novo Nordisk INC | $508.04 | 2019-2021 | |
| Glaxosmithkline, LLC. | $188.48 | 2021-2023 | |
| Amgen INC. | $156.96 | 2020-2022 | |
| Axsome Therapeutics, INC. | $109.07 | 2023 | Auvelity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $76.29 | 2020-2021 | |
| Almatica Pharma LLC | $60.93 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.95 | 2022 | |
| Grifols USA, LLC | $45.08 | 2024 | Prolastin-C Liquid |
| Janssen Pharmaceuticals, INC | $40.09 | 2021 | |
| Sun Pharmaceutical Industries INC. | $37.66 | 2020-2022 | |
| Pfizer INC. | $36.97 | 2019-2020 | |
| Abbvie INC. | $15.26 | 2024 | |
| Amneal Pharmaceuticals LLC | $13.98 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $12.34 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $11.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jean Lang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.